Reprise Biomedical
Mr. Nalbone is Vice President of Corporate Development at Imperative Care, Inc., a commercial-stage medical device company focused on technologies that address the continuum of stroke care. Prior to joining Imperative Care, Phil spent seven years at Vascular Solutions, Inc. as VP of Corporate Development and Investor Relations, and after Vascular Solutions was acquired by Teleflex, Inc., Phil continued in management at Teleflex in the company’s Corporate Development and Strategy group. Before moving to the corporate side, Phil spent 20 years on Wall Street as an analyst following the medical device industry at such firms as Hambrecht & Quist, Volpe Brown Whelan, Salomon Smith Barney, and RBC Capital Markets.
This person is not in the org chart
This person is not in any offices
Reprise Biomedical
Reprise Biomedical is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019.